Australia markets closed

TFF Pharmaceuticals, Inc. (TFFP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.2000+0.0200 (+1.69%)
At close: 04:00PM EST
1.2400 +0.04 (+3.33%)
After hours: 07:53PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 31.13M
Enterprise value 18.19M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.73
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.53

Trading information

Stock price history

Beta (5Y monthly) 1.44
52-week change 3-83.31%
S&P500 52-week change 3-11.22%
52-week high 39.9600
52-week low 31.0600
50-day moving average 32.6312
200-day moving average 34.9488

Share statistics

Avg vol (3-month) 3222.42k
Avg vol (10-day) 3366.43k
Shares outstanding 525.52M
Implied shares outstanding 6N/A
Float 820.43M
% held by insiders 125.41%
% held by institutions 116.69%
Shares short (14 Nov 2022) 4735.49k
Short ratio (14 Nov 2022) 42.39
Short % of float (14 Nov 2022) 42.97%
Short % of shares outstanding (14 Nov 2022) 42.88%
Shares short (prior month 13 Oct 2022) 4704.33k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 0.00%
Operating margin (ttm)-17,696.77%

Management effectiveness

Return on assets (ttm)-62.05%
Return on equity (ttm)-104.75%

Income statement

Revenue (ttm)195.02k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)75.20%
Gross profit (ttm)-21.21M
EBITDA -34.17M
Net income avi to common (ttm)-34.45M
Diluted EPS (ttm)-1.2510
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)13.15M
Total cash per share (mrq)0.51
Total debt (mrq)208.15k
Total debt/equity (mrq)1.15
Current ratio (mrq)8.18
Book value per share (mrq)0.71

Cash flow statement

Operating cash flow (ttm)-30.52M
Levered free cash flow (ttm)-21.52M